URGN
Urogen Pharma Ltd
Price:  
40.97 
USD
Volume:  
421,251.00
Israel | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

URGN Stock Forecast & Price Target

URGN Stock Price Forecast

The average stock forecast for Urogen Pharma Ltd (URGN) in the next 12 months is 37.61 USD. This price target corresponds to an upside of -14.09%. The range of stock forecasts for URGN is 18.18 - 47.25 USD. Based on the ratings of 14 analysts, the consensus recommendation for URGN is STRONGBUY.
Target Low Average Median High
Price (USD) 18.18 37.61 40.80 47.25
Upside -58.47% -14.09% -6.81% 7.93%

Recommendation Trends

The latest consensus rating for URGN is "STRONGBUY". This is the average recommendation of 14 analysts: 0 strong sell, 0 sell, 2 hold, 6 buy, 6 strong buy. In the previous period, 14 analysts also majorly recommmended "BUY" for URGN.

URGN Financial Stock Forecast

Revenue This Year
274.62M
150.14%
from 109.79M
Revenue Next Year
428.17M
55.91%
from 274.62M
EPS This Year
-0.79
-74.95%
from -3.15
EPS Next Year
1.39
-276.48%
from -0.79